Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement. This agreement grants Lilly exclusive, worldwide rights to research, develop, manufacture, ...

An injection pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., December 11, 2023. In its Thursday open letter, Eli Lilly issued a major warning to consumers ...

A woman holds a Mounjaro injectible pen. Eli Lilly, the maker of Mounjaro and Zepbound, warned of the dangers of counterfeit drugs in an open letter Thursday, stating people should never use drugs ...

drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply as it sees continued high demand. Instead of a preloaded injector pen, patients will ...

Eli Lilly has slashed the prices of starter doses of Zepbound to “significantly” expand the supply of the popular weight loss drug amid high demand in the United States. Single-dose vials ...

Eli Lilly is announcing a new way to get its popular ... thereby causing weight loss. An injection pen of Zepbound, a weight loss drug, is displayed in New York, Dec. 11, 2023.

Eli Lilly said it has begun selling ... It has previously said patients could get the drug in a pen through LillyDirect for as little as $550. Lilly said the prices were in line with its current ...